Department of Chemistry, University of Karachi, Karachi-75270,Pakistan.
Department of Chemistry and Earth Sciences, Qatar University, Doha,Qatar.
Med Chem. 2022;18(1):97-114. doi: 10.2174/1573406417666210216160941.
A combination of biologically active ligand and metal in one molecule may increase the activity and reduce the toxicity.
In this study, the synthesis and characterization of platinum(IV) complexes with bioactive hydrazide ligands are discussed.
Elemental analysis, conductivity measurements, and spectroscopic studies were used to elucidate the structure of complexes.
Our study suggests that hydrazide ligands coordinate with Pt(IV) in a bidentate fashion. The platinum(IV) complexes have octahedral geometry with a metal to ligand ratio of 1:2. Hydrazide ligands were coordinated with central metal platinum(IV) by oxygen of carbonyl group and nitrogen of primary amine. Synthesized complexes exhibited variable DPPH radical scavenging and lipoxygenase inhibition activity. Furthermore, it is also found that Pt(IV)-hydrazide complexes are more potent superoxide and nitric oxide radical scavengers than their uncoordinated hydrazide ligands, while in the case of lipoxygenase enzyme inhibition, some of the free hydrazide ligands are more active than their respective Pt(IV) complexes. In silico docking technique explores molecular interactions of synthesized ligands in the active site of the lipoxygenase enzyme. Predicted docking energies are in good agreement with experimental data suggesting that in silico studies might be useful for the discovery of therapeutic candidates.
Structure-function relationship demonstrates that the radical scavenging and enzyme inhibition activities of the Pt(IV) compounds are affected by the nature of the ligand, position of substituent, electronic and steric effects. However, electronic factors seem to play a more important role than other factors.
将生物活性配体和金属结合在一个分子中可能会提高活性并降低毒性。
本研究讨论了具有生物活性酰肼配体的铂(IV)配合物的合成与表征。
采用元素分析、电导率测量和光谱研究来阐明配合物的结构。
我们的研究表明,酰肼配体以双齿配位的方式与 Pt(IV)配位。铂(IV)配合物具有八面体几何构型,金属与配体的比例为 1:2。酰肼配体通过羰基的氧和伯胺的氮与中心金属铂(IV)配位。合成的配合物表现出可变的 DPPH 自由基清除和脂氧合酶抑制活性。此外,还发现 Pt(IV)-酰肼配合物比其未配位的酰肼配体更有效地清除超氧自由基和一氧化氮自由基,而在脂氧合酶抑制活性方面,一些游离酰肼配体比其相应的 Pt(IV)配合物更活跃。分子对接技术探讨了合成配体在脂氧合酶活性部位的分子相互作用。预测的对接能与实验数据吻合较好,表明计算研究可能有助于发现治疗候选物。
结构-功能关系表明,Pt(IV)化合物的自由基清除和酶抑制活性受配体的性质、取代基的位置、电子和空间效应的影响。然而,电子因素似乎比其他因素起着更重要的作用。